<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>critical care biomarkers &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/critical-care-biomarkers/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 29 Nov 2025 00:08:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>critical care biomarkers &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Plasma LPS Levels Predict Mortality in Sick Children</title>
		<link>https://bioengineer.org/plasma-lps-levels-predict-mortality-in-sick-children/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 29 Nov 2025 00:08:16 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biyobelirteçler]]></category>
		<category><![CDATA[çocuklarda kritik bakım]]></category>
		<category><![CDATA[critical care biomarkers]]></category>
		<category><![CDATA[düşük-orta gelirli ülkeler **Virgülle ayrılmış etiketler:** `plasma LPS levels]]></category>
		<category><![CDATA[endotoxin-mediated mortality`]]></category>
		<category><![CDATA[hastalık mortalitesi]]></category>
		<category><![CDATA[LMIC healthcare]]></category>
		<category><![CDATA[pediatric mortality prediction]]></category>
		<category><![CDATA[Plazma LPS düzeyleri]]></category>
		<guid isPermaLink="false">https://bioengineer.org/plasma-lps-levels-predict-mortality-in-sick-children/</guid>

					<description><![CDATA[In a groundbreaking study poised to reshape pediatric critical care in Low- and Middle-Income Countries (LMICs), scientists have identified plasma lipopolysaccharide (LPS) levels as a potent predictor of mortality in acutely ill children. This critical discovery not only provides novel mechanistic insights into the pathophysiology of severe pediatric illnesses but also holds transformative potential for [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">303065</post-id>	</item>
		<item>
		<title>CRP-Albumin Ratio Links to Pediatric Mortality Risk</title>
		<link>https://bioengineer.org/crp-albumin-ratio-links-to-pediatric-mortality-risk/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 27 Oct 2025 13:52:48 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[critical care biomarkers]]></category>
		<category><![CDATA[CRP-albumin ratio]]></category>
		<category><![CDATA[inflammatory and nutritional markers]]></category>
		<category><![CDATA[pediatric intensive care outcomes]]></category>
		<category><![CDATA[pediatric mortality]]></category>
		<guid isPermaLink="false">https://bioengineer.org/crp-albumin-ratio-links-to-pediatric-mortality-risk/</guid>

					<description><![CDATA[In a groundbreaking retrospective cohort study, researchers including Chang, Zhang, and Wang have unveiled a significant finding regarding the C-reactive protein-to-albumin ratio (CAR) and its association with mortality in critically ill pediatric patients. This research could change the landscape of pediatric critical care, providing an essential tool to predict outcomes and enhance clinical decision-making. As [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">287118</post-id>	</item>
		<item>
		<title>Immune Cell ‘Signatures’ May Pave the Way for Personalized Treatment in Critically Ill Patients</title>
		<link>https://bioengineer.org/immune-cell-signatures-may-pave-the-way-for-personalized-treatment-in-critically-ill-patients/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 30 Sep 2025 10:44:17 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[AI-driven diagnostic algorithms]]></category>
		<category><![CDATA[antibiotic stewardship]]></category>
		<category><![CDATA[critical care biomarkers]]></category>
		<category><![CDATA[precision immunomodulatory therapies]]></category>
		<category><![CDATA[sepsis immune profiling]]></category>
		<guid isPermaLink="false">https://bioengineer.org/immune-cell-signatures-may-pave-the-way-for-personalized-treatment-in-critically-ill-patients/</guid>

					<description><![CDATA[In the chaotic realm of emergency medicine, where minutes can mean the difference between life and death, physicians face a relentless challenge: swiftly diagnosing infections and determining the best course of treatment. The complexity intensifies in critical cases such as sepsis, where the body’s immune response can veer dramatically from one patient to another. Now, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">273677</post-id>	</item>
	</channel>
</rss>
